Paolo Tombesi
Overview
Paolo Tombesi received $5M in total compensation, including $205K in salary, at Turning Point Therapeutics in 2021. Paolo Tombesi also received an average of $2M at Epizyme between 2019 and 2020 and an average of $2M at INSMED from 2017 to 2019.
Source: SEC filings on April 29, 2022, April 29, 2021, April 17, 2020, March 31, 2020, April 4, 2019, and April 5, 2018.
Related executives
We found 43 more executives who work or worked at Turning Point Therapeutics, Epizyme, andINSMED.
Athena Countouriotis
Turning Point Therapeutics
Chief Executive Officer
Mohammad Hirmand
Turning Point Therapeutics
Chief Medical Officer
Annette North
Turning Point Therapeutics
General Counsel
Siegfried PHD
Turning Point Therapeutics
Chief Scientific Officer
Yi Larson
Turning Point Therapeutics
Chief Financial Officer
Brian Baker
Turning Point Therapeutics
Former Senior Vice President, Finance and Administration
Robert Bazemore
Epizyme
Chief Executive Officer
William Lewis
INSMED
Chief Executive Officer
News
Turning Point Therapeutics CEO Athena Countouriotis' 2021 pay rises 11% to $17M
April 29, 2022
Epizyme CEO Robert Bazemore's 2020 pay jumps 103% to $8.5M
April 29, 2021
Epizyme CEO Robert Bazemore's 2019 pay rises 14% to $4.2M
April 17, 2020
INSMED CEO William Lewis' 2019 pay jumps 21% to $7.2M
March 31, 2020
INSMED CEO William Lewis' 2018 pay jumps 37% to $5.9M
April 4, 2019